作者
- Antman, E.M. (4)
- Armstrong, P.W. (4)
- Braunwald, E. (4)
- Califf, R.M. (5)
- Cannon, C.P. (4)
- Giugliano, R.P. (4)
- McCabe, C.H. (4)
- Topol, E.J. (6)
- White, H.D. (6)
- Wilcox, R.G. (14)
|
總筆數:14
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Cigarette smoking status and outcome among patients with acute coronarysyndromes without persistent ST-segment elevation: Effect of inhibition ofplatelet glycoprotein IIb/IIIa with eptifibatide |
Hasdai, D.;Holmes, D.R.;Criger, D.A.;Topol, E.J.;Califf, R.M.;Wilcox, R.G.;Paolasso, E.;Simoons, M.;Deckers, J.;Harrington, R.A.;The PURSUIT trial investigators; |
American Heart Journal |
2000-03-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
Wong, C.-K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.M.;for the GUSTO-III Investigators; |
American Heart Journal |
2000-12-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
Wong, C.K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.;for the GUSTO-III Investigators; |
American Heart Journal |
2000-12-01 |
查看 |
| New atrial fibrillation after acute myocardial infarction independentlypredicts death: The GUSTO-III experience |
for the GUSTO-III Investigators;Wong, C.K.;White, H.D.;Wilcox, R.G.;Criger, D.A.;Califf, R.M.;Topol, E.J.;Ohman, E.; |
American Heart Journal |
2000-12-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; |
American Heart Journal |
2001-05-01 |
查看 |
| The relationship between baseline risk and mortality in ST-elevationacute myocardial infarction treated with pharmacological reperfusion:Insights from the Global Utilization of Strategies To open Occludedarteries (GUSTO) V trial |
for the GUSTO V Investigators;Brener, S.J.;Lincoff, A.M.;Bates, E.R.;Jia, G.;Armstrong, P.W.;Guetta, V.;Hochman, J.S.;Savonitto, S.;Wilcox, R.G.;White, H.D.;Topol, E.J.; |
American Heart Journal |
2005-07-01 |
查看 |
| The relationship between baseline risk and mortality in ST-elevationacute myocardial infarction treated with pharmacological reperfusion:Insights from the Global Utilization of Strategies To open Occludedarteries (GUSTO) V trial |
for the GUSTO V Investigators;Brener, S.J.;Lincoff, A.M.;Bates, E.R.;Jia, G.;Armstrong, P.W.;Guetta, V.;Hochman, J.S.;Savonitto, S.;Wilcox, R.G.;White, H.D.;Topol, E.J.; |
American Heart Journal |
2005-07-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
| Unexplained international differences in clinical outcomes after acutemyocardial infarction and fibrinolytic therapy: Lessons from the Hirulogand Early Reperfusion or Occlusion (HERO)-2 trial |
for the HERO-2 Investigators;Simes, R.J.;O'Connell, R.L.;Aylward, P.E.;Varshavsky, S.;Diaz, R.;Wilcox, R.G.;Armstrong, P.W.;Granger, C.B.;French, J.K.;Van de Werf, F.;Marschner, I.C.;Califf, R.;White, H.D.; |
American Heart Journal |
2010-06-01 |
查看 |
| Refining clinical trial composite outcomes: An application to theAssessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3)trial |
Armstrong, P.W.;Westerhout, C.M.;Van de Werf, F.;Califf, R.M.;Welsh, R.C.;Wilcox, R.G.;Bakal, J.A.; |
American Heart Journal |
2011-05-01 |
查看 |
|
|
|
